PRKN and hepatocellular carcinoma: The results showed that, compared to untransfected control cells, parkin siRNA-treated A549 and HCC-1588 cells were arrested in sub G0/G1 phase (Fig 3A and 3B), and this was accompanied by a significant decrease in the number of cells in the G1 phase.